Trump administration tells Idaho it needs to stick with ObamaCare


On Thursday, the Centers for Medicare and Medicaid Services (CMS) shot down Idaho's bid to allow lower-cost, lower-coverage health insurance plans that don't comply with the Affordable Care Act. ObamaCare "remains the law, and we have a duty to enforce and uphold the law," CMS Administrator Seema Verma said in a letter to Idaho Gov. C.L. "Butch" Otter (R) and the head of the state's insurance department. Verma, who pushed for repealing ObamaCare, did not seem enthusiastic about denying Idaho's bid, and she said that "with certain modifications," its proposal might pass muster.
In January, Otter signed an executive order paving the way for cheaper health plans that allow higher premiums for people with pre-existing conditions, cap the amount of coverage allowed, and exclude the suite of "essential health benefits" required under the ACA. Blue Cross of Idaho had proposed five such plans to be launched in April, but Veema said if Idaho fails to "substantially enforce" ObamaCare, the federal government will step in as "primary enforcer." Idaho said "dozens" of other red states had expressed interest in its plan to flout ObamaCare, though none has followed through.
ObamaCare supporters were pleased but not overly impressed by the CMS move. "The Trump administration is talking out of both sides of their mouth," said Sen. Ron Wyden (D-Ore.). "While they claim to be upholding the law, they are explicitly inviting Idaho and other states to sell short-term, junk insurance — the exact opposite of the protections put in place by the Affordable Care Act."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Wonsan-Kalma: North Korea's new 'mammoth' beach resort
Under the Radar Pyongyang wants to boost tourism but there won't be many foreign visitors to Kim Jong Un's 'pet project'
-
The 5 best TV reboots of all time
The Week Recommends Finding an entirely new cast to play beloved characters is harder than it looks
-
Sudoku hard: July 10, 2025
The Week's daily hard sudoku puzzle
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths